Nidymo (Melatonin)

Melatonin, the active ingredient in Nidymo, is a melatonin receptor agonist presented as an oral dosage form for oral use. It helps regulate the sleep‑wake cycle and is used in adults who experience insomnia, difficulty falling asleep, or jet‑lag. GNH USA supplies Nidymo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nidymo, a melatonin receptor agonist, acts on the circadian rhythm pathway to improve sleep quality. - Insomnia: promotes sleep initiation and maintenance in individuals with difficulty staying asleep. - Sleep onset difficulties: reduces the time required to fall asleep in patients with delayed sleep phase. - Jet lag: helps realign the internal clock after rapid trans‑meridian travel, easing daytime fatigue.

Nidymo may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate discomfort often occurring after the first dose. - Dizziness: transient light‑headedness, especially when standing quickly. - Daytime sleepiness: residual drowsiness if taken too late. - Nausea: mild stomach upset after ingestion. - Vivid dreams: unusual or intense dreaming patterns. - Mild gastrointestinal discomfort: occasional abdominal cramping.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling of face or throat. - Depression or mood changes: worsening of depressive symptoms in susceptible individuals. - Severe hypotension: marked drop in blood pressure leading to faintness. - Hallucinations: rare visual or auditory disturbances. - Suicidal thoughts: emergent in patients with underlying psychiatric conditions.

Before using Nidymo, consider the following safety measures. - Assess underlying conditions: evaluate for depression, seizure disorders, or severe hepatic impairment. - Avoid alcohol: concurrent consumption may increase sedation. - Pregnancy: consult a healthcare professional before use. - Elderly patients: start with the lowest effective dose due to increased sensitivity. - Review concomitant medications: check for potential drug interactions. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and light.

Melatonin can interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce melatonin efficacy. - Central nervous system depressants (e.g., benzodiazepines): additive sedation.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): may alter melatonin metabolism. - Oral contraceptives: can raise plasma melatonin concentrations. - Beta‑blockers: may blunt endogenous melatonin production.